Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Cirrhosis

  Free Subscription

Articles published in Z Gastroenterol

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    January 2024
  1. BEDNARSCH J, Lang SA, Heise D, Strnad P, et al
    Laparoscopic Living donor liver transplantation in irresectable intrahepatic cholangiocarcinoma in primary sclerosing cholangitis associated liver cirrhosis.
    Z Gastroenterol. 2024;62:50-55.
    PubMed     Abstract available

  2. GUNDLACH JP, Ellrichmann M, van Rosmalen M, Vogelaar S, et al
    Liver transplantation for HCC in cirrhosis: Are Milan criteria outdated?
    Z Gastroenterol. 2024;62:43-49.
    PubMed     Abstract available

    October 2023
  3. PAZOUKI R, Hasselblatt P, Kugler C
    Prevalence of delirium in gastroenterology/hepatology units: A cross-sectional study.
    Z Gastroenterol. 2023;61:1357-1364.
    PubMed     Abstract available

    May 2023
  4. XIANG Q, Xiong J, Zhao ZJ, Zhou T, et al
    Walking exercise through smartphone application plus branched-chain amino acid supplementation benefits skeletal muscle mass and strength in liver cirrhosis: A prospective control trial.
    Z Gastroenterol. 2023 May 23. doi: 10.1055/a-2075-0130.
    PubMed     Abstract available

  5. WALLSTAB F, Jechorek D, Keitel-Anselmino V, Arnim UV, et al
    [Ligandrol-induced liver injury - Case Report].
    Z Gastroenterol. 2023;61:522-525.
    PubMed     Abstract available

    April 2023
  6. DONG Y, Koch J, Alhyari A, Safai Zadeh E, et al
    Ultrasound Elastography for Characterization of Focal Liver Lesions.
    Z Gastroenterol. 2023;61:399-410.
    PubMed     Abstract available

  7. SLIWINSKI S, Trojan J, Mader C, Vogl T, et al
    Liver resection after Transjugular Portosystemic Stent Shunt (TIPSS).
    Z Gastroenterol. 2023;61:390-393.
    PubMed     Abstract available

    February 2023
  8. DANNECKER FD, Aschenbach R, Teichgraber U, Reuken P, et al
    [Successful therapy of non-cirrhotic non-malignant portal vein thrombosis (NCNMPT) by interventional therapy using transjugular lysis catheter].
    Z Gastroenterol. 2023 Feb 3. doi: 10.1055/a-1967-2223.
    PubMed     Abstract available

    January 2023
  9. ORTNER J, Van Ewijk RJ, Velthuis L, Labenz C, et al
    Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35.
    Z Gastroenterol. 2023 Jan 9. doi: 10.1055/a-1989-1971.
    PubMed     Abstract available

    [Innate and adaptive immunity in the context of non-alcoholic fatty liver disease].
    Z Gastroenterol. 2023;61:76-82.
    PubMed     Abstract available

  11. GEIER A, Rau M, Pathil-Warth A, von der Ohe M, et al
    Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry.
    Z Gastroenterol. 2023;61:60-70.
    PubMed     Abstract available

  12. ROHR L, Lemmer P, Henning M, Tannapfel A, et al
    Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases.
    Z Gastroenterol. 2023;61:29-36.
    PubMed     Abstract available

    November 2022
  13. MOLLER K, Safai Zadeh E, Gorg C, Dong Y, et al
    Prevalence of benign focal liver lesions and non-hepatocellular carcinoma malignant lesions in liver cirrhosis.
    Z Gastroenterol. 2022 Nov 22. doi: 10.1055/a-1890-5818.
    PubMed     Abstract available

  14. GAIRING SJ, Schleicher EM, Muller L, Labenz C, et al
    Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case report.
    Z Gastroenterol. 2022 Nov 15. doi: 10.1055/a-1959-2660.
    PubMed     Abstract available

  15. MUCKE MM, Bruns T, Canbay A, Matzdorff A, et al
    [Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures].
    Z Gastroenterol. 2022 Nov 14. doi: 10.1055/a-1934-1867.
    PubMed     Abstract available

    September 2022
  16. FRUNDT T, Schroder N, Holzemer A, Pinnschmidt H, et al
    Prevalence and risk factors of undiagnosed diabetes mellitus among gastroenterological patients: a HbA1c-based single center experience - Prevalence of undiagnosed diabetes in gastroenterological patients.
    Z Gastroenterol. 2022;60:1306-1313.
    PubMed     Abstract available

    August 2022
  17. DIETRICH CF, Shi L, Lowe A, Dong Y, et al
    Conventional ultrasound for diagnosis of hepatic steatosis is better than believed.
    Z Gastroenterol. 2022;60:1235-1248.
    PubMed     Abstract available

    July 2022
  18. KRUGER K, Rossol S, Krauth C, Buggisch P, et al
    Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).
    Z Gastroenterol. 2022 Jul 15. doi: 10.1055/a-1852-5713.
    PubMed     Abstract available

    January 2022
  19. KRAG A, Roskams T, Pinzani M, Mueller S, et al
    Diagnostic challenges in patients with alcohol-related liver disease.
    Z Gastroenterol. 2022;60:45-57.
    PubMed     Abstract available

    November 2021
  20. LABENZ C, Kostev K, Galle PR, Worns MA, et al
    Prescription rates of common medications in patients with decompensated cirrhosis in Germany.
    Z Gastroenterol. 2021 Nov 24. doi: 10.1055/a-1676-4822.
    PubMed     Abstract available

  21. KACZMAREK DJ, Kupczyk P, Schultheiss M, Chang J, et al
    TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension.
    Z Gastroenterol. 2021 Nov 5. doi: 10.1055/a-1508-6446.
    PubMed     Abstract available

    September 2021
  22. HONER ZU SIEDERDISSEN C, Schultalbers M, Wubbolding M, Lechte GS, et al
    Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
    Z Gastroenterol. 2021;59:954-960.
    PubMed     Abstract available

    August 2021
  23. STAHMEYER JT, Hemmerling M, Burger B, Eberhard S, et al
    [Frequency of diagnosed non-alcololic fatty liver disease (NAFLD) in the German population - An analysis based on health insurance data].
    Z Gastroenterol. 2021;59:851-858.
    PubMed     Abstract available

    June 2021
  24. SCURT FG, Bose K, Canbay A, Mertens PR, et al
    [Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options].
    Z Gastroenterol. 2021;59:560-579.
    PubMed     Abstract available

    March 2021
  25. KUBESCH A, Peiffer KH, Abramowski H, Dultz G, et al
    The presence of liver cirrhosis is a strong negative predictor of survival for patients admitted to the intensive care unit - Cirrhosis in intensive care patients.
    Z Gastroenterol. 2021 Mar 16. doi: 10.1055/a-1401-2387.
    PubMed     Abstract available

    January 2021
  26. GAIRING SJ, Kloeckner R, Pitton MB, Baumgart J, et al
    Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.
    Z Gastroenterol. 2021;59:43-49.
    PubMed     Abstract available

    December 2020
  27. MICHEL M, Schattenberg JM
    [Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]
    Z Gastroenterol. 2020;58:1233-1240.
    PubMed     Abstract available

    November 2020
  28. MUCKE MM, Miesbach W, Peiffer KH, Mucke VT, et al
    [Management of hemostasis in gastroenterology critical care].
    Z Gastroenterol. 2020;58:1099-1106.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.